ATE19057T1 - Arzneimittel die das reaktionprodukt von einer carbonsaeure und einer basischen amino-saeure enthalten. - Google Patents

Arzneimittel die das reaktionprodukt von einer carbonsaeure und einer basischen amino-saeure enthalten.

Info

Publication number: ATE19057T1
Authority: AT; Austria
Prior art keywords: acid; basic amino; medications; contain; reaction product
Prior art date: 1981-07-03

Application number

AT82401236T

Other languages

English (en)

Inventor

Charles Chany

Italina Nee Burolla Cerutti

Original Assignee

Charles Chany

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-07-03

Filing date

1982-07-01

Publication date

1986-04-15

1982-07-01 Application filed by Charles Chany filed Critical Charles Chany

1986-04-15 Application granted granted Critical

1986-04-15 Publication of ATE19057T1 publication Critical patent/ATE19057T1/de

Links

150000001413 amino acids Chemical class 0.000 title abstract 3
229940079593 drug Drugs 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title 1
239000002253 acid Substances 0.000 title 1
229910052799 carbon Inorganic materials 0.000 title 1
239000007795 chemical reaction product Substances 0.000 title 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 abstract 4
239000004475 Arginine Substances 0.000 abstract 2
WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 2
239000004472 Lysine Substances 0.000 abstract 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
230000000259 anti-tumor effect Effects 0.000 abstract 2
230000000840 anti-viral effect Effects 0.000 abstract 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 2
GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 abstract 2
150000001735 carboxylic acids Chemical class 0.000 abstract 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 abstract 2
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT82401236T 1981-07-03 1982-07-01 Arzneimittel die das reaktionprodukt von einer carbonsaeure und einer basischen amino-saeure enthalten. ATE19057T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8113190A FR2508797B1 (fr)	1981-07-03	1981-07-03	Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
EP82401236A EP0069659B1 (de)	1981-07-03	1982-07-01	Arzneimittel die das Reaktionprodukt von einer Carbonsäure und einer basischen Amino-säure enthalten

Publications (1)

Publication Number	Publication Date
ATE19057T1 true ATE19057T1 (de)	1986-04-15

Family

ID=9260209

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT82401236T ATE19057T1 (de)	1981-07-03	1982-07-01	Arzneimittel die das reaktionprodukt von einer carbonsaeure und einer basischen amino-saeure enthalten.

Country Status (7)

Country	Link
EP (1)	EP0069659B1 (de)
JP (1)	JPS5813512A (de)
AT (1)	ATE19057T1 (de)
CA (1)	CA1209037A (de)
DE (1)	DE3270388D1 (de)
FR (1)	FR2508797B1 (de)
ZA (1)	ZA824726B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2587900B1 (fr) *	1985-10-01	1988-10-07	Morelle Jean	Associations acides gras-acides amines basiques, douees de proprietes emollientes, emulsifiantes et antioxydantes, destinees a la cosmetique, la dermatologie et l'alimentation
US4883661A (en) *	1987-10-09	1989-11-28	Daly John M	Use of arginine as an lymphokine synergist
HU209973B (en) *	1988-03-09	1995-01-30	Biorex Kutato Fejlesztoe Kft	Process for production of antiviral and immunstimular pharmaceutical composition
AT393080B (de) *	1988-11-25	1991-08-12	Lubec Gert	Pharmazeutische verwendung von arginin (salzen)
US5955080A (en) *	1991-07-26	1999-09-21	Commonwealth Scientific And Industrial Research Organisation	Self-adjuvanting peptide vaccine delivery system and production thereof
US7910624B1 (en)	1995-03-03	2011-03-22	The Trustees Of Boston University	Compositions for the treatment of blood disorders
AU696167B2 (en) *	1993-10-29	1998-09-03	Trustees Of Boston University	Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
US6011000A (en) *	1995-03-03	2000-01-04	Perrine; Susan P.	Compositions for the treatment of blood disorders
EP1611885A1 (de) *	1996-07-26	2006-01-04	Susan P. Perrine	Verwendung eines induzierenden Wirkstoffes zur Behandlung von Blut, Viralen und zellulären Störungen
US6197743B1 (en)	1996-07-26	2001-03-06	The Trustees Of Boston University	Compositions and methods for the treatment of viral disorders
DE19753321A1 (de) *	1997-12-02	1999-06-10	Basf Ag	Verfahren zur Herstellung und Verwendung von Lysinformiat
WO1999040883A2 (en)	1998-02-11	1999-08-19	Faller Douglas V	Compositions and methods for the treatment of cystic fibrosis
US20110086869A1 (en)	2009-09-24	2011-04-14	The Trustees Of Boston University	Methods for treating viral disorders
CN102802412A (zh)	2009-12-08	2012-11-28	海玛奎斯特医药公司	用于治疗红细胞病症的方法及低剂量方案
US20110245154A1 (en)	2010-03-11	2011-10-06	Hemaquest Pharmaceuticals, Inc.	Methods and Compositions for Treating Viral or Virally-Induced Conditions
JP7373991B2 (ja)	2016-07-15	2023-11-06	ビラクタセラピューティクス，インク．	免疫療法で使用するためのヒストン脱アセチル化酵素阻害剤
SG11202113215UA (en)	2019-05-31	2021-12-30	Viracta Subsidiary Inc	Methods of treating virally associated cancers with histone deacetylase inhibitors
CN113698893B (zh) *	2021-09-17	2022-07-08	吉林大学	一种由氨基酸与脂肪酸形成的热熔胶及其制备方法
EP4643657A1 (de)	2024-04-30	2025-11-05	Velocity Life Sciences, LLC	Zusammensetzungen mit kurzkettiger fettsäure, verfahren zur verwendung und verfahren zur herstellung davon
US12226383B1 (en)	2024-04-30	2025-02-18	Velocity Life Sciences, LLC	Compositions containing short-chain fatty acid, methods of use, and methods of making thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2662046A (en) *	1948-06-19	1953-12-08	Merck & Co Inc	Parenteral amino acid solution
US3024272A (en) *	1958-04-22	1962-03-06	Du Pont	Organic acid salts of basic amino acids and their use
JPS5535049A (en) *	1978-09-04	1980-03-11	Otsuka Pharmaceut Factory Inc	Amino acid transfusion for cancerous patient

1981
- 1981-07-03 FR FR8113190A patent/FR2508797B1/fr not_active Expired
1982
- 1982-07-01 DE DE8282401236T patent/DE3270388D1/de not_active Expired
- 1982-07-01 AT AT82401236T patent/ATE19057T1/de not_active IP Right Cessation
- 1982-07-01 EP EP82401236A patent/EP0069659B1/de not_active Expired
- 1982-07-02 JP JP57115306A patent/JPS5813512A/ja active Pending
- 1982-07-02 ZA ZA824726A patent/ZA824726B/xx unknown
- 1982-07-02 CA CA000406505A patent/CA1209037A/en not_active Expired

Also Published As

Publication number	Publication date
FR2508797B1 (fr)	1986-03-14
ZA824726B (en)	1983-04-27
EP0069659B1 (de)	1986-04-09
EP0069659A1 (de)	1983-01-12
CA1209037A (en)	1986-08-05
DE3270388D1 (en)	1986-05-15
FR2508797A1 (fr)	1983-01-07
JPS5813512A (ja)	1983-01-26

Similar Documents

Publication	Publication Date	Title
ATE19057T1 (de)	1986-04-15	Arzneimittel die das reaktionprodukt von einer carbonsaeure und einer basischen amino-saeure enthalten.
AU642913B2 (en)	1993-11-04	New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and the manufacture and use of said compounds
FR2395296A1 (fr)	1979-01-19	Utilisation d'esters d'acides carboxyliques et d'alkylolamines tertiaires pour le traitement de pigments en matieres de charge inorganiques dont on veut ameliorer la dispersabilite
NL191332C (nl)	1995-06-01	Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
SE410312B (sv)	1979-10-08	Forfarande for framstellning av vissa angivna oximetrar
FR2362817A1 (fr)	1978-03-24	Acides cyclopropane-carboxyliques et leur procede de preparation
DK440985A (da)	1986-05-21	Enzymatisk proces
GB8607137D0 (en)	1986-04-30	Compositions
ATE74346T1 (de)	1992-04-15	Alkensaeurederivate.
ATE26213T1 (de)	1987-04-15	Aeusserlich anzuwendende arzneimittelzubereitung enthaltend adenosin zur behandlung von herpes.
NO175307C (no)	1994-09-28	Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer)
MY107357A (en)	1995-11-30	Process for making olefins
OA05233A (fr)	1981-02-28	Procédé de préparation d'acides (7-acétamido Disubstitue)-3- substitue-3- cephem-4-carboxyliques et nouveaux produits industriels.
ATE11774T1 (de)	1985-02-15	Verfahren zur herstellung von 1,4-dihydro-4-oxo- chinolin-2-carbonsaeuren oder salzen, estern oder amiden davon und zwischenverbindungen dafuer.
IL73060A0 (en)	1984-12-31	Process for the racemization of optically active aminoacids
JPS552671A (en)	1980-01-10	Manufacture of oxazolidinee2*44diones
EP0055172A3 (en)	1982-08-04	Process for the stabilisation of the biologic activity of degradable liposoluble nutrients, products obtained and dietetic and therapeutic use
FR2708929B1 (fr)	1996-05-15	Procédé de préparation d'esters d'acide cyclopropane-1,1-dicarboxylique.
BE818046A (fr)	1975-01-24	Procede pour la production de methacroleine a partir d'isobutene et d'oxygene en presence de catalyseurs et catalyseurs concernes
GB1438078A (en)	1976-06-03	Decolourization of carbonyl compounds
PT70367A (en)	1979-11-01	Process for the preparation of 4,4-dimethyl-4-sila-fatty acid amides with pharmaceutical effect
ATE104940T1 (de)	1994-05-15	Trennung von 1,2-dihydroxycyclohexa-3,5-dienverbindungen.
ATE582T1 (de)	1982-02-15	N-benzoyl-retinylamine, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische mittel und die verwendung dieser verbindungen bei der therapie und prophylaxe von praekanzerosen und karzinomen der haut.
GB1359588A (en)	1974-07-10	Process for the production of thiodipropionic acid compounds
DE3261924D1 (en)	1985-02-28	Process for the preparation of 3,3-dimethylglutaric acid or its esters

Legal Events

Date	Code	Title	Description
1986-09-15	UEP	Publication of translation of european patent specification
1990-04-15	REN	Ceased due to non-payment of the annual fee